The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial
Open accessAbstract
BACKGROUND: Actinic keratoses (AKs) are established as direct precursors of squamous cell carcinoma (SCC), but there is significant controversy regarding the rate at which AKs progress to SCC. The authors of this report studied a high‐risk population to estimate the risk of progression of AK to SCC and to basal cell carcinoma (BCC) and the risk of spontaneous regression of untreated AKs. METHODS: Data were obtained from participants in the Department of Veterans Affairs Topical Tretinoin Chemoprevention Trial. Participants were examined every 6 months for up to 6 years. At each examination, the locations on the face and ears of clinically diagnosed AKs and lesions scheduled for biopsy were marked, and high‐resolution digital photographs were taken. These photographs were used later to map and track the presence, absence, or biopsy of each AK across visits. RESULTS: In total, 7784 AKs were identified on the face and ears of 169 participants. The risk of progression of AK to primary SCC (invasive or in situ) was 0.60% at 1 year and 2.57% at 4 years. Approximately 65% of all primary SCCs and 36% of all primary BCCs diagnosed in the study cohort arose in lesions that previously were diagnosed clinically as AKs. The majority of AKs (55%) that were followed clinically were not present at the 1‐year follow‐up, and the majority (70%) were not present at the 5‐year follow‐up. CONCLUSIONS: In the current study, the authors quantified the malignant potential of clinically diagnosed AKs for both SCC and BCC, although many did not persist, and the results suggested that AKs may play a greater role in the overall burden of keratinocyte carcinomas than previously documented. Cancer 2009. Published 2009 by the American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bickers (2006) · doi:10.1016/j.jaad.2006.05.048 · Cited by 741
MALIGNANT TRANSFORMATION OF SOLAR KERATOSES TO SQUAMOUS CELL CARCINOMA
Marks, R., Rennie, G., & Selwood, T. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91658-3 · Cited by 658
High Sun Protection Factor Sunscreens in the Suppression of Actinic Neoplasia
Naylor, M. F. (1995) · Archives of Dermatology · doi:10.1001/archderm.131.2.170 · Cited by 420
Self-citationActinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification
Röwert-Huber, J., Patel, M. J., Forschner, T., Ulrich, C., Eberle, J., Kerl, H., Sterry, W., & Stockfleth, E. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07860.x · Cited by 380
OCKELBO DISEASE: EPIDEMIC ARTHRITIS-EXANTHEMA SYNDROME IN SWEDEN CAUSED BY SINDBIS-VIRUS LIKE AGENT
Skogh, M., & Espmark, Å. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91834-7 · Cited by 346
Spontaneous remission of solar keratoses: the case for conservative management
MARKS, R., FOLEY, P., GOODMAN, G., HAGE, B. H., & SELWOOD, T. S. (1986) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1986.tb06644.x · Cited by 319
Dodson, J. M. (1991) · Archives of Dermatology · doi:10.1001/archderm.127.7.1029 · Cited by 268
Epidemiology of solar keratoses
FROST, C. A., & GREEN, A. C. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08544.x · Cited by 256
Solar (actinic) keratosis is squamous cell carcinoma
Ackerman, A. B., & Mones, J. M. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.07121.x · Cited by 226
Frequency of pre‐existing actinic keratosis in cutaneous squamous cell carcinoma
Mittelbronn, M. A., Mullins, D. L., Ramos‐Caro, F. A., & Flowers, F. P. (1998) · International Journal of Dermatology · doi:10.1046/j.1365-4362.1998.00467.x · Cited by 196
Cited by
Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches
Apalla, Z., Nashan, D., Weller, R. B., & Castellsagué, X. (2017) · Dermatology and Therapy · doi:10.1007/s13555-016-0165-y · Cited by 465
Genomic Analysis of Metastatic Cutaneous Squamous Cell Carcinoma
Li, Y. Y., Hanna, G. J., Laga, A. C., Haddad, R. I., Lorch, J. H., & Hammerman, P. S. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1773 · Cited by 285
Actinic keratosis: a clinical and epidemiological revision
Schmitt, J. V., & Miot, H. A. (2012) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962012000300012 · Cited by 120
Mancebo, S. E. (2014) · doi:10.1016/j.det.2014.03.011 · Cited by 119
A review of BF-200 ALA for the photodynamic treatment of mild-to-moderate actinic keratosis
Reinhold, U. (2017) · Future Oncology · doi:10.2217/fon-2017-0247 · Cited by 46
Metadata
- Authors
- Criscione, V. D., Weinstock, M. A., Naylor, M. F., Luque, C., Eide, M. J., Bingham, S. F., & for the Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial Group
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2009-05-20
- Volume
- 115
- Issue
- 11
- Pages
- 2523-2530
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2044030923
- Cited by
- 432
- References
- 27
- FWCI
- 10.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. https://app.cochat.ai/papers/10.1002/cncr.24284
- The paper
- Criscione, V. D., Weinstock, M. A., Naylor, M. F., Luque, C., Eide, M. J., Bingham, S. F., & for the Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial Group. (2009). Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Cancer. https://doi.org/10.1002/cncr.24284
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.